Overview

An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants

Status:
Completed

Trial end date:
2008-06-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to evaluate the efficacy of oxybutynin chloride oral osmotic therapeutic system (OROS) on patient-reported outcomes after 12 weeks of treatment by dose escalation in participants with overactive bladder.

Phase:

Phase 4

Details

Lead Sponsor:

Janssen Korea, Ltd., Korea

Treatments:

Mandelic Acids
Oxybutynin